文献速递神经免疫认知障碍与痴呆

多发性硬化颈髓萎缩演变中临床相关的头尾模式

Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
PubMed 文献 · Neurology · 2019-10-14

研究基于179名对照和435例多发性硬化患者的多中心数据,分析颈髓萎缩分布及纵向演变。结果显示患者基线颈髓横截面积归一化值低于对照,随访1年内除临床孤立综合征外各表型均出现萎缩,早期复发缓解型和临床恶化者萎缩速率最高。

要点

  • 多发性硬化患者颈髓萎缩在复发缓解型始于C1/C2至C5,进展型更广泛。
  • 随访1年除临床孤立综合征外所有表型颈髓横截面积均下降。
  • 早期复发缓解型及临床恶化者萎缩速率最高,需样本量118例检测50%疗效。

核心结论

  • 多发性硬化患者颈髓萎缩在1年内进展,临床孤立综合征除外,更快萎缩可解释临床恶化。

主要发现

  • 患者基线颈髓横截面积归一化值低于对照(p < 0.001),但对照与临床孤立综合征、早期复发缓解型(病程≤5年)与临床孤立综合征之间无差异。
  • 晚期复发缓解型(病程>5年)较早期复发缓解型出现显著颈髓萎缩(p = 0.02),进展型较复发缓解型颈髓横截面积归一化值降低(p < 0.001)。
  • 复发缓解型较临床孤立综合征萎缩位于C1/C2至C5,进展型较复发缓解型沿颈髓更广泛,继发进展型较原发进展型额外累及C5/C6。
  • 随访时除临床孤立综合征外所有表型颈髓横截面积归一化值均下降(p < 0.001),早期复发缓解型和临床恶化者萎缩速率最高且累及更广泛。
  • 检测50%治疗效应所需每组样本量:早期复发缓解型患者为118例。

临床怎么用

  • 颈髓横截面积归一化值可作为多发性硬化疾病进展和临床恶化的影像标志物。
  • 早期复发缓解型患者萎缩速率高,提示需密切监测和积极干预。

局限性

  • 随访时间仅1年,长期演变模式未明确。
  • 样本量在部分亚组(如临床孤立综合征35例、原发进展型42例)较小,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the distribution and regional evolution of cervical cord atrophy in patients with multiple sclerosis (MS) in a multicenter dataset. METHODS: MRI and clinical evaluations were acquired from 179 controls and 435 patients (35 clinically isolated syndromes [CIS], 259 relapsing-remitting multiple sclerosis [RRMS], 99 secondary progressive multiple sclerosis [SPMS], and 42 primary progressive multiple sclerosis [PPMS]). Sixty-nine controls and 178 patients underwent a 1-year MRI and clinical follow-up. Patients were classified as clinically stable/worsened according to their disability change. Longitudinal changes of cord atrophy were investigated with linear mixed-effect models. Sample size calculations were performed using age-, sex- and site-adjusted annualized percentage normalized cord cross-sectional area (CSAn) changes. RESULTS: Baseline CSAn was lower in patients with MS vs controls (p < 0.001), but not different between controls and patients with CIS or between patients with early RRMS (disease duration ≤5 years) and patients with CIS. Patients with late RRMS (disease duration >5 years) showed significant cord atrophy vs patients with early RRMS (p = 0.02). Patients with progressive MS had decreased CSAn (p < 0.001) vs patients with RRMS. Atrophy was located between C1/C2 and C5 in patients with RRMS vs patients with CIS, and widespread along the cord in patients with progressive MS vs patients with RRMS, with an additional C5/C6 involvement in patients with SPMS vs patients with PPMS. At follow-up, CSAn decreased in all phenotypes (p < 0.001), except CIS. Cord atrophy rates were highest in patients with early RRMS and clinically worsened patients, who had a more widespread cord involvement than stable patients. The sample size per arm required to detect a 50% treatment effect was 118 for patients with early RRMS. CONCLUSIONS: Cord atrophy increased in MS during 1 year, except for CIS. Faster atrophy contributed to explain clinical worsening.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Rocca MA, Valsasina P, Meani A, et al. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS. Neurology. 2019. PMID: 31611336. doi:10.1212/WNL.0000000000008466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。